REVELATION BIOSCIENCES, INC. Diluted Shares Outstanding (Weighted Average)
REVELATION BIOSCIENCES, INC. (REVB) reported Diluted Shares Outstanding (Weighted Average) of 3.83 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2026-08-06
- REVELATION BIOSCIENCES, INC. weighted average number of shares outstanding, diluted for the quarter ending 2026-06-30 was 3.83M shares, a 1808.31% increase year-over-year.
- REVELATION BIOSCIENCES, INC. weighted average number of shares outstanding, diluted for the quarter ending 2026-03-31 was 3.21M shares, a 3862.94% increase year-over-year.
- REVELATION BIOSCIENCES, INC. weighted average number of shares outstanding, diluted for the quarter ending 2025-12-31 was -1.31M shares.
- REVELATION BIOSCIENCES, INC. weighted average number of shares outstanding, diluted for the quarter ending 2025-09-30 was 2.64M shares, a 4636.95% increase year-over-year.
- REVELATION BIOSCIENCES, INC. weighted average number of shares outstanding, diluted for fiscal 2025 was 620.78K shares, a 4243.28% increase from fiscal 2024.
- REVELATION BIOSCIENCES, INC. weighted average number of shares outstanding, diluted for fiscal 2024 was 14.29K shares, a 0.33% increase from fiscal 2023.
- REVELATION BIOSCIENCES, INC. weighted average number of shares outstanding, diluted for fiscal 2023 was 14.25K shares, a 80.37% decline from fiscal 2022.
- REVELATION BIOSCIENCES, INC. weighted average number of shares outstanding, diluted for fiscal 2022 was 72.58K shares, a 74.26% decline from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Diluted 3 month | Weighted Average Number of Shares Outstanding, Diluted 3 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 6 month | Weighted Average Number of Shares Outstanding, Diluted 6 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 9 month | Weighted Average Number of Shares Outstanding, Diluted 9 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 12 month | Weighted Average Number of Shares Outstanding, Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 3.83M shares 10-Q · filed 2026-08-06 | 3.52M shares 10-Q · filed 2026-08-06 | 1.91M shares derived: average of 3 quarters · filed 2026-08-06 | 2.09M shares derived: average of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | 3.21M shares 10-Q · filed 2026-05-07 | 947.07K shares derived: average of 2 quarters · filed 2026-05-07 | 1.51M shares derived: average of 3 quarters · filed 2026-05-07 | 1.18M shares derived: average of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | -1.31M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | 665.58K shares derived: average of 2 quarters · filed 2026-02-26 | 510.61K shares derived: average of 3 quarters · filed 2026-08-06 | 620.78K shares 10-K · filed 2026-02-26 | ||||
| 2025-09-30 | 2.64M shares 10-Q · filed 2025-11-06 | 1.42M shares derived: average of 2 quarters · filed 2026-08-06 | 1.27M shares 10-Q · filed 2025-11-06 | 717.68K shares derived: average of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | 200.67K shares 10-Q · filed 2026-08-06 | 802.67K shares 10-Q · filed 2025-08-08 | 141.14K shares 10-Q · filed 2026-08-06 | 564.56K shares 10-Q · filed 2025-08-08 | 75.33K shares derived: average of 3 quarters · filed 2026-08-06 | 70.45K shares derived: average of 4 quarters · filed 2026-08-06 | ||
| 2025-03-31 | 80.94K shares 10-Q · filed 2026-05-07 | 971.31K shares 10-Q · filed 2025-05-08 | 12.65K shares derived: average of 2 quarters · filed 2026-05-07 | 27.05K shares derived: average of 3 quarters · filed 2026-05-07 | 28.80K shares derived: average of 4 quarters · filed 2026-05-07 | |||
| 2024-12-31 | -55.63K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | 99.00 shares derived: average of 2 quarters · filed 2026-02-26 | 11.42K shares derived: average of 3 quarters · filed 2026-02-26 | 14.29K shares 10-K · filed 2026-02-26 | 171.51K shares 10-K · filed 2025-03-06 | |||
| 2024-09-30 | 55.83K shares 10-Q · filed 2025-11-06 | 2.68M shares 10-Q · filed 2024-11-08 | 44.95K shares derived: average of 2 quarters · filed 2025-11-06 | 37.60K shares 10-Q · filed 2025-11-06 | 1.80M shares 10-Q · filed 2024-11-08 | -112.83K shares derived: average of 4 quarters · filed 2025-11-06 | ||
| 2024-06-30 | 34.07K shares 10-Q · filed 2025-08-08 | 1.64M shares 10-Q · filed 2024-08-09 | 28.39K shares 10-Q · filed 2025-08-08 | 1.36M shares 10-Q · filed 2024-08-09 | -169.05K shares derived: average of 3 quarters · filed 2025-08-08 | -60.66K shares derived: average of 4 quarters · filed 2025-08-08 | ||
| 2024-03-31 | 68.11K shares 10-Q · filed 2025-05-08 | 1.09M shares 10-Q · filed 2024-05-10 | -270.62K shares derived: average of 2 quarters · filed 2025-05-08 | -92.23K shares derived: average of 3 quarters · filed 2025-05-08 | -7.08K shares derived: average of 4 quarters · filed 2025-05-08 | |||
| 2023-12-31 | -609.35K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | -172.40K shares derived: average of 2 quarters · filed 2025-03-06 | -32.15K shares derived: average of 3 quarters · filed 2025-03-06 | 14.25K shares 10-K · filed 2025-03-06 | 228.64K shares 10-K · filed 2024-03-22 | |||
| 2023-09-30 | 264.54K shares 10-Q · filed 2024-11-08 | 6.30M shares 10-Q · filed 2023-11-09 | 256.45K shares derived: average of 2 quarters · filed 2024-11-08 | 222.11K shares 10-Q · filed 2024-11-08 | 5.02M shares 10-Q · filed 2023-11-09 | -125.57K shares derived: average of 4 quarters · filed 2024-11-08 | ||
| 2023-06-30 | 248.37K shares 10-Q/A · filed 2024-09-23 | 5.81M shares 10-Q · filed 2023-08-11 | 197.17K shares 10-Q/A · filed 2024-09-23 | 3.07M shares 10-Q · filed 2023-08-11 | -255.61K shares derived: average of 3 quarters · filed 2024-09-23 | -38.71K shares derived: average of 4 quarters · filed 2024-09-23 | ||
| 2023-03-31 | 166.14K shares 10-Q/A · filed 2024-09-23 | 3.14M shares 10-Q · filed 2023-05-22 | -507.60K shares derived: average of 2 quarters · filed 2024-09-23 | -134.40K shares derived: average of 3 quarters · filed 2024-09-23 | 9.54K shares derived: average of 4 quarters · filed 2024-09-23 | |||
| 2022-12-31 | -1.18M shares derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-09-23 | -284.67K shares derived: average of 2 quarters · filed 2024-09-23 | -42.67K shares derived: average of 3 quarters · filed 2024-09-23 | 72.58K shares 10-K/A · filed 2024-09-23 | 539.04K shares 10-K · filed 2023-03-30 | |||
| 2022-09-30 | 612.00K shares 10-Q · filed 2023-11-09 | 21.06M shares 10-Q · filed 2022-11-10 | 526.67K shares derived: average of 2 quarters · filed 2023-11-09 | 490.56K shares 10-Q · filed 2023-11-09 | 16.81M shares 10-Q · filed 2022-11-10 | -940.79K shares derived: average of 4 quarters · filed 2023-11-09 | ||
| 2022-06-30 | 441.35K shares 10-Q · filed 2023-08-11 | 15.08M shares 10-Q · filed 2022-08-15 | 428.84K shares 10-Q · filed 2023-08-11 | 14.64M shares 10-Q · filed 2022-08-15 | -1.46M shares derived: average of 3 quarters · filed 2023-08-11 | 479.13K shares derived: average of 4 quarters · filed 2023-08-11 | ||
| 2022-03-31 | 416.18K shares 10-Q · filed 2023-05-22 | -2.41M shares derived: average of 2 quarters · filed 2023-05-22 | 491.73K shares derived: average of 3 quarters · filed 2023-05-22 | 1.94M shares derived: average of 4 quarters · filed 2023-05-22 | ||||
| 2021-12-31 | -5.23M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | 529.50K shares derived: average of 2 quarters · filed 2023-03-30 | 2.45M shares derived: average of 3 quarters · filed 2023-03-30 | 282.04K shares 10-K · filed 2023-03-30 | ||||
| 2021-09-30 | 6.29M shares 10-Q · filed 2022-11-10 | 6.29M shares derived: average of 2 quarters · filed 2022-11-10 | 2.12M shares 10-Q · filed 2022-11-10 | |||||
| 2021-06-30 | 6.29M shares 10-Q · filed 2022-08-15 | 3.16M shares 10-Q · filed 2022-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |